FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023113445> ?p ?o ?g. }

• W2023113445 endingPage "2187" @default.
• W2023113445 startingPage "2180" @default.
• W2023113445 abstract "Isolated hepatic perfusion (IHP) with melphalan is an established approach for patients with unresectable metastatic liver lesions. This study determined the safety and maximum tolerated dose (MTD) of 5-FU with oxaliplatin via IHP.Standard 3 × 3 Phase I design. Subjects with unresectable isolated CRC liver metastases scheduled for HAI pump were eligible. IHP used fixed-dose oxaliplatin with escalating 5-FU doses. Toxicity (CTCAE v 4.0) and response (RECIST), progression-free survival, and overall survival (OS) were assessed. Systemic and IHP plasma PK of 5-FU, anabolites, and platinum were determined.All 12 patients had received ≥ 1 line of pre-IHP chemotherapy. There were 4 grade 3 serious adverse events (33.3 %) and 1 grade 4 event (8.3 %). Also, 2 dose-limiting toxicities occurred at DL2 at 300 mg/m(2), resulting in expansion of DL1 at 200 mg/m(2) 5-FU, the eventual MTD. At 6-month follow-up, 9 patients (82 %) demonstrated partial response, while 2 (18 %) exhibited stable disease. Also, 64 % of patients demonstrated a >50 % decrease in CEA. The 1- and 2-year OS probabilities were 90.9 and 71.6 %, respectively, with median follow-up of 24 months. IHP exposures (AUC0-60 min) were 10.9 ± 4.5 μgPt h/mL, 49.3 ± 30.7 μg h/mL 5-FU (DL1), and 70.5 ± 35.5 μg h/mL 5-FU (DL2). Systemic exposure (AUC0-inf) relative to IHP exposure was negligible for both platinum (1.1 ± 1.5 %) and 5-FU (0.09 ± 0.10 %).The MTD for IHP was 200 mg/m(2) 5-FU with 40 mg/m(2) oxaliplatin. Systemic exposure to the agents was minimal during IHP. The response and survival observed warrants assessment in a larger phase II trial." @default.
• W2023113445 created "2016-06-24" @default.
• W2023113445 creator A5024180293 @default.
• W2023113445 creator A5026123944 @default.
• W2023113445 creator A5030889960 @default.
• W2023113445 creator A5032048592 @default.
• W2023113445 creator A5043540755 @default.
• W2023113445 creator A5044474059 @default.
• W2023113445 creator A5050352682 @default.
• W2023113445 creator A5051030840 @default.
• W2023113445 creator A5054409783 @default.
• W2023113445 creator A5073859061 @default.
• W2023113445 creator A5081560714 @default.
• W2023113445 creator A5088208693 @default.
• W2023113445 date "2013-04-11" @default.
• W2023113445 modified "2023-10-01" @default.
• W2023113445 title "A Phase I Trial of Isolated Hepatic Perfusion (IHP) Using 5-FU and Oxaliplatin in Patients with Unresectable Isolated Liver Metastases from Colorectal Cancer" @default.
• W2023113445 cites W1961040537 @default.
• W2023113445 cites W1970979885 @default.
• W2023113445 cites W1976550982 @default.
• W2023113445 cites W1982174595 @default.
• W2023113445 cites W1986924507 @default.
• W2023113445 cites W2023388702 @default.
• W2023113445 cites W2026140821 @default.
• W2023113445 cites W2028547579 @default.
• W2023113445 cites W2033578575 @default.
• W2023113445 cites W2036642961 @default.
• W2023113445 cites W2044224410 @default.
• W2023113445 cites W2051224942 @default.
• W2023113445 cites W2066444442 @default.
• W2023113445 cites W2073016557 @default.
• W2023113445 cites W2082866635 @default.
• W2023113445 cites W2084470612 @default.
• W2023113445 cites W2085070000 @default.
• W2023113445 cites W2121368761 @default.
• W2023113445 cites W2128813634 @default.
• W2023113445 cites W2131239494 @default.
• W2023113445 cites W2139671422 @default.
• W2023113445 cites W2154009817 @default.
• W2023113445 cites W2162313061 @default.
• W2023113445 cites W2166443789 @default.
• W2023113445 cites W2167676775 @default.
• W2023113445 cites W2203518391 @default.
• W2023113445 cites W2269945922 @default.
• W2023113445 cites W2274798216 @default.
• W2023113445 cites W2410900275 @default.
• W2023113445 cites W4884274 @default.
• W2023113445 doi "https://doi.org/10.1245/s10434-013-2960-3" @default.
• W2023113445 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3808182" @default.
• W2023113445 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23575907" @default.
• W2023113445 hasPublicationYear "2013" @default.
• W2023113445 type Work @default.
• W2023113445 sameAs 2023113445 @default.
• W2023113445 citedByCount "9" @default.
• W2023113445 countsByYear W20231134452012 @default.
• W2023113445 countsByYear W20231134452014 @default.
• W2023113445 countsByYear W20231134452016 @default.
• W2023113445 countsByYear W20231134452017 @default.
• W2023113445 countsByYear W20231134452018 @default.
• W2023113445 countsByYear W20231134452019 @default.
• W2023113445 crossrefType "journal-article" @default.
• W2023113445 hasAuthorship W2023113445A5024180293 @default.
• W2023113445 hasAuthorship W2023113445A5026123944 @default.
• W2023113445 hasAuthorship W2023113445A5030889960 @default.
• W2023113445 hasAuthorship W2023113445A5032048592 @default.
• W2023113445 hasAuthorship W2023113445A5043540755 @default.
• W2023113445 hasAuthorship W2023113445A5044474059 @default.
• W2023113445 hasAuthorship W2023113445A5050352682 @default.
• W2023113445 hasAuthorship W2023113445A5051030840 @default.
• W2023113445 hasAuthorship W2023113445A5054409783 @default.
• W2023113445 hasAuthorship W2023113445A5073859061 @default.
• W2023113445 hasAuthorship W2023113445A5081560714 @default.
• W2023113445 hasAuthorship W2023113445A5088208693 @default.
• W2023113445 hasBestOaLocation W20231134452 @default.
• W2023113445 hasConcept C121608353 @default.
• W2023113445 hasConcept C126322002 @default.
• W2023113445 hasConcept C126894567 @default.
• W2023113445 hasConcept C143998085 @default.
• W2023113445 hasConcept C197934379 @default.
• W2023113445 hasConcept C2776694085 @default.
• W2023113445 hasConcept C2778405590 @default.
• W2023113445 hasConcept C2779984678 @default.
• W2023113445 hasConcept C2780140570 @default.
• W2023113445 hasConcept C2780962732 @default.
• W2023113445 hasConcept C31760486 @default.
• W2023113445 hasConcept C526805850 @default.
• W2023113445 hasConcept C71924100 @default.
• W2023113445 hasConcept C90924648 @default.
• W2023113445 hasConceptScore W2023113445C121608353 @default.
• W2023113445 hasConceptScore W2023113445C126322002 @default.
• W2023113445 hasConceptScore W2023113445C126894567 @default.
• W2023113445 hasConceptScore W2023113445C143998085 @default.
• W2023113445 hasConceptScore W2023113445C197934379 @default.
• W2023113445 hasConceptScore W2023113445C2776694085 @default.
• W2023113445 hasConceptScore W2023113445C2778405590 @default.
• W2023113445 hasConceptScore W2023113445C2779984678 @default.
• W2023113445 hasConceptScore W2023113445C2780140570 @default.
• W2023113445 hasConceptScore W2023113445C2780962732 @default.

• next